{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:06:11Z","timestamp":1790233571309,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006545","name":"U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["K99 MD014738"],"award-info":[{"award-number":["K99 MD014738"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM115428"],"award-info":[{"award-number":["U54 GM115428"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM104357"],"award-info":[{"award-number":["P20 GM104357"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM104357"],"award-info":[{"award-number":["P20 GM104357"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00 HL146888"],"award-info":[{"award-number":["R00 HL146888"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-022-00682-0","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T07:04:43Z","timestamp":1649401483000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antihypertensive effects of immunosuppressive therapy in autoimmune disease"],"prefix":"10.1038","volume":"37","author":[{"given":"John S.","family":"Clemmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Hillegass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0122-0833","authenticated-orcid":false,"given":"Erin B.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"682_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-016-0571-2","volume":"18","author":"CE Fors Nieves","year":"2016","unstructured":"Fors Nieves CE, Izmirly PM. Mortality in Systemic Lupus Erythematosus: an Updated Review. Curr Rheumatol Rep. 2016;18:21.","journal-title":"Curr Rheumatol Rep."},{"key":"682_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3899\/jrheum.101132","volume":"38","author":"JM Sabio","year":"2011","unstructured":"Sabio JM, Vargas-Hitos JA, Navarrete-Navarrete N, Mediavilla JD, Jimenez-Jaimez J, Diaz-Chamorro A, et al. Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus. J Rheumatol 2011;38:1026\u201332.","journal-title":"J Rheumatol"},{"key":"682_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.semarthrit.2013.07.007","volume":"43","author":"K Tselios","year":"2014","unstructured":"Tselios K, Koumaras C, Urowitz MB, Gladman DD. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal. Semin Arthritis Rheum. 2014;43:521\u20135.","journal-title":"Semin Arthritis Rheum."},{"key":"682_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/annrheumdis-2019-216764","volume":"79","author":"K Tselios","year":"2020","unstructured":"Tselios K, Gladman DD, Su J, Urowitz M. Impact of the new American College of Cardiology\/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Ann Rheum Dis. 2020;79:612\u20137.","journal-title":"Ann Rheum Dis."},{"key":"682_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345.","journal-title":"Ann Rheum Dis."},{"key":"682_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1751-7176.2008.07758.x","volume":"10","author":"E Grossman","year":"2008","unstructured":"Grossman E, Messerli FH. Secondary hypertension: interfering substances. J Clin Hypertens. 2008;10:556\u201366.","journal-title":"J Clin Hypertens"},{"key":"682_CR7","doi-asserted-by":"crossref","unstructured":"Taylor EB, Ryan MJ. Immunosuppression with mycophenolate mofetil attenuates hypertension in an experimental model of autoimmune disease. J Am Heart Assoc. 2017;6:e005394.","DOI":"10.1161\/JAHA.116.005394"},{"key":"682_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.114.03587","volume":"64","author":"M Gomez-Guzman","year":"2014","unstructured":"Gomez-Guzman M, Jimenez R, Romero M, Sanchez M, Zarzuelo MJ, Gomez-Morales M, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 2014;64:330\u20137.","journal-title":"Hypertension"},{"key":"682_CR9","doi-asserted-by":"publisher","unstructured":"UMMC. University of Mississippi Medical Center, Center for Informatics and Analytics. Patient Cohort Explorer (2020). https:\/\/doi.org\/10.6084\/m9.figshare.12252737.v2.","DOI":"10.6084\/m9.figshare.12252737.v2"},{"key":"682_CR10","first-page":"493","volume":"30","author":"A Al-Herz","year":"2003","unstructured":"Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol. 2003;30:493\u20136.","journal-title":"J Rheumatol."},{"key":"682_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/rheumatology\/ken159","volume":"47","author":"VF Panoulas","year":"2008","unstructured":"Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Hypertension in rheumatoid arthritis. Rheumatology. 2008;47:1286\u201398.","journal-title":"Rheumatology"},{"key":"682_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.38239","volume":"66","author":"SS Lim","year":"2014","unstructured":"Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis Rheumatol. 2014;66:357\u201368.","journal-title":"Arthritis Rheumatol."},{"key":"682_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","volume":"97","author":"B Rodriguez-Iturbe","year":"2017","unstructured":"Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97:1127\u201364.","journal-title":"Physiol Rev."},{"key":"682_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/bph.14604","volume":"176","author":"EB Taylor","year":"2019","unstructured":"Taylor EB, Wolf VL, Dent E, Ryan MJ. Mechanisms of hypertension in autoimmune rheumatic diseases. Br J Pharmacol. 2019;176:1897\u2013913.","journal-title":"Br J Pharmacol."},{"key":"682_CR15","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/ar3473","volume":"13","author":"M Nikpour","year":"2011","unstructured":"Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther. 2011;13:R156.","journal-title":"Arthritis Res Ther."},{"key":"682_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00467-011-1928-4","volume":"27","author":"JE Goodwin","year":"2012","unstructured":"Goodwin JE, Geller DS. Glucocorticoid-induced hypertension. Pediatr Nephrol. 2012;27:1059\u201366.","journal-title":"Pediatr Nephrol."},{"key":"682_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11906-004-0046-0","volume":"6","author":"S Baid","year":"2004","unstructured":"Baid S, Nieman LK. Glucocorticoid excess and hypertension. Curr Hypertens Rep. 2004;6:493\u20139.","journal-title":"Curr Hypertens Rep."},{"key":"682_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","volume":"51","author":"G Ruiz-Irastorza","year":"2012","unstructured":"Ruiz-Irastorza G, Danza A, Khamashta M. Glucocorticoid use and abuse in SLE. Rheumatology. 2012;51:1145\u201353.","journal-title":"Rheumatology"},{"key":"682_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/acr.23880","volume":"72","author":"JS Gandelman","year":"2020","unstructured":"Gandelman JS, Khan OA, Shuey MM, Neal JE, McNeer E, Dickson A, et al. Increased incidence of resistant hypertension in patients with systemic lupus erythematosus: a retrospective cohort study. Arthritis Care Res. 2020;72:534\u201343.","journal-title":"Arthritis Care Res"},{"key":"682_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:480\u20139.","journal-title":"Ann Rheum Dis."},{"key":"682_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1759720X17719850","volume":"9","author":"AA Mangoni","year":"2017","unstructured":"Mangoni AA, Baghdadi LR, Shanahan EM, Wiese MD, Tommasi S, Elliot D, et al. Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study. Ther Adv Musculoskelet Dis. 2017;9:213\u201329.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"682_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0961203313519159","volume":"23","author":"R Sakthiswary","year":"2014","unstructured":"Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus. 2014;23:225\u201335.","journal-title":"Lupus."},{"key":"682_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrrheum.2009.235","volume":"6","author":"T Dorner","year":"2010","unstructured":"Dorner T. Therapy: hydroxychloroquine in SLE: old drug, new perspectives. Nat Rev Rheumatol. 2010;6:10\u20131.","journal-title":"Nat Rev Rheumatol."},{"key":"682_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/FJC.0b013e31829dd857","volume":"62","author":"G Stojan","year":"2013","unstructured":"Stojan G, Petri M. Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol. 2013;62:255\u201362.","journal-title":"J Cardiovasc Pharmacol."},{"key":"682_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.phrs.2016.09.008","volume":"113","author":"CG McCarthy","year":"2016","unstructured":"McCarthy CG, Wenceslau CF, Goulopoulou S, Ogbi S, Matsumoto T, Webb RC. Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats. Pharm Res. 2016;113:384\u201394.","journal-title":"Pharm Res."},{"key":"682_CR26","doi-asserted-by":"publisher","first-page":"s2","DOI":"10.1191\/0961203305LU2109OA","volume":"14","author":"AC Allison","year":"2005","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005;14:s2\u20138.","journal-title":"Lupus."},{"key":"682_CR27","doi-asserted-by":"publisher","first-page":"e000310","DOI":"10.1136\/lupus-2018-000310","volume":"6","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Bertsias G. Changing paradigms in the treatment of systemic lupus erythematosus. Lupus Sci Med. 2019;6:e000310.","journal-title":"Lupus Sci Med."},{"key":"682_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11906-020-01081-x","volume":"22","author":"PI Georgianos","year":"2020","unstructured":"Georgianos PI, Agarwal R. Resistant Hypertension in Chronic Kidney Disease (CKD): prevalence, treatment particularities, and research agenda. Curr Hypertens Rep. 2020;22:84.","journal-title":"Curr Hypertens Rep."},{"key":"682_CR29","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1681\/ASN.2006080918","volume":"17","author":"J Herrera","year":"2006","unstructured":"Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006;17:S218\u201325.","journal-title":"J Am Soc Nephrol."},{"key":"682_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol. 2009;20:1103\u201312.","journal-title":"J Am Soc Nephrol."},{"key":"682_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1136\/ard.2010.131995","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, D\u2019Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, et al. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis. 2010;69:2083\u20139.","journal-title":"Ann Rheum Dis."},{"key":"682_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-014-2802-0","volume":"34","author":"SS Shaharir","year":"2015","unstructured":"Shaharir SS, Mustafar R, Mohd R, Mohd Said MS, Gafor HA. Persistent hypertension in lupus nephritis and the associated risk factors. Clin Rheumatol. 2015;34:93\u20137.","journal-title":"Clin Rheumatol."},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1191\/096120399678847704","volume":"8","author":"GS Alarcon","year":"1999","unstructured":"Alarcon GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999;8:197\u2013209.","journal-title":"Lupus."},{"key":"682_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0002-9343(02)01118-X","volume":"112","author":"VA Seligman","year":"2002","unstructured":"Seligman VA, Lum RF, Olson JL, Li H, Criswell LA. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med. 2002;112:726\u20139.","journal-title":"Am J Med."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-022-00682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-022-00682-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-022-00682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T10:04:46Z","timestamp":1680170686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-022-00682-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1038\/s41371-022-00682-0","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Data from this study was generated using the University of Mississippi Medical Center Research Data Warehouse. The data is in this repository is extracted from the electronic health record system (Epic) and de-identified and are thus exempt from IRB approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}